Pharmaceutical Raw Materials
Veterinary API
Pharmaceutical Intermediates
Biochemicals
Pharmaceutical Excipients
Other Chemical Drugs
Blood System Drugs
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Antibiotics
Synthetic Anti Infective Drugs
Antipyretic Analgesics
Antiallergic Drugs
Fluid, Electrolyte, and Acid-Base Balance
Vitamins and Minerals Medicines
Urinary System Drugs
Digestive System Drugs
Antiparasitic Drugs
Anesthetic Agents
Hormones and Endocrine Drugs
Diagnostic Agents
Circulatory System Drugs
Immune System Medication
Anti Stress Drugs
Inhibitors
Drug Metabolism
Specialty Drugs
Feed Drug Additive
CAS:159989-64-7
Molecular Formula:C33H49N3O7S2
Alias
More Information
Viracept (Tn); Nelfinavir (Inn); Nelfinavir Monomethane Sulfonate; Viracept; [3H]-Nelfinavir; [14C]-Nelfinavir; (3S,4As,8As)-2-[(2R,3R)-2-Hydroxy-3-(3-Hydroxy-2-Methylbenzoylamino)-4-Phenylthiobutyl]Decahydroisoquinoline-3-Carboxylic Acid T-Butylamide; (3S,4As,8As)-N-Tert-Butyl-2-[(2R,3R)-2-Hydroxy-3-[(3-Hydroxy-2-Methylbenzoyl)Amino]-4-Phenylsulfanylbutyl]-3,4,4A,5,6,7,8,8A-Octahydro-1H-Isoquinoline-3-Carboxamide; [3S-(3R*,4Ar*,8Ar*,2'S*,3'S*)]-2-[2'-Hydroxy-3'-Phenylthiomethyl-4'-Aza-5'-Oxo-5'-(2''-Methyl-3''-Hydroxyphenyl)Pentyl]Decahydroisoquinoline-3-N-T-Butylcarboxamide; N-Tert-Butyl-2-[2-Hydroxy-3-[[(3-Hydroxy-2-Methylphenyl)-Oxomethyl]Amino]-4-(Phenylthio)Butyl]-3,4,4A,5,6,7,8,8A-Octahydro-1H-Isoquinoline-3-Carboxamide; 3-Isoquinolinecarboxamide,N-(1,1-Dimethylethyl)Decahydro-2-(2-Hydroxy-3-((3-Hy; 8A-Beta))-A-Bet; (3S,4As,8As)-N-(1,1-Dimethylethyl)Decahydro-2-[(2R,3R)-2-Hydroxy-3-[(3-Hydroxy-2-Methylbenzoyl)Amino]-4-(Phenylthio)Butyl]-3-Isoquinolinecarboxamide
Brief Introduction
An effective oral bioavailable HIV-1 protease inhibitor for HIV infection. Nifenavir is a broad-spectrum anticancer agent.
CAS:165800-06-6
Molecular Formula:C5H12N2O8P2
Alias
More Information
(1-Hydroxy-2-Imidazol-1-Yl-1-Phosphonoethyl)Phosphonic Acid,Hydrate; Zoledronic Acid Monohydrate; (1-Hydroxy-2-(1H-Imidazol-1-Yl)Ethane-1,1-Diyl)Diphosphonic Acid Hydrate; 1-Hydroxy-2-(1-Imidazolyl)Ethane-1,1-Diphosphonic Acid Monohydrate
Brief Introduction
Zoledronic acid monohydrate can be an effective osteoclast inhibitor, which can induce osteoclast apoptosis by inhibiting the enzyme of methylglutaric acid pathway and preventing the isoprene of small GTP binding proteins such as Ras and Rho.
CAS:17902-23-7
Molecular Formula:C8H9FN2O3
Alias
More Information
Riol; Neberk; Exonal; Tetrahydrofuryl-5-Fluorouracil; 5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione; Fulaid; Lifril; Ft-207; 5-Fluoro-1-(Tetrahydro-2-Furyl)Uracil; 5-Fluoro-1-(Tetrahydro-2-Furfuryl)Uracil; Fental; Fluaid; Lamar; Nitobanil; Nsc-148958; Phthorafur; Sinoflurol; Sunfral; 5-Fluoro-1-(Tetrahydro-2-Fuanyl)-2,4-(1H,3H)-Pyrimidinedione, Citofur, Exonal, Fental,
Brief Introduction
This product is a derivative of 5-fluorouracil, with the same function and use as 5-fluorouracil, but with low toxicity and high chemotherapy index. In vivo, it is activated by liver enzymes and converted into 5-fluorouracil to play an anticancer role. It is effective for gastric cancer, colon cancer, rectal cancer, pancreatic cancer, breast cancer and lung cancer.
CAS:183319-69-9
Molecular Formula:C22H24ClN3O4
Alias
More Information
Erlotinib-D6 Hcl; Erlotinib Hcl Salt; Erlotinib Hcl; N-(3-Ethynylphenyl)-6,7-Bis(2-Methoxyethoxy)Quinazolin-4-Amine Hydrochloride; Erlotinib,Os-774; Erlotinib (Hydrochloride)
Brief Introduction
Erotinib hydrochloride is a reversible inhibitor of small molecule epidermal growth factor receptor tyrosine kinase, which is mainly used in the second-line or third-line treatment of locally advanced or metastatic non-small cell lung cancer and the treatment of pancreatic cancer.
Alias
More Information
Lapatinib (2Tsoh); 4-{[3-Chloro-4-(3-Fluoro-Benzyloxy)-Phenyl]Amino}-6-(5-{[(2-Methansulfonyl-Ethyl)Amino]Methyl}-Furan-2-Yl)Quinazoline; N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methanesulphonyl)Ethyl]Amino}Methyl)-Furan-2-Yl]-4-Quinazolinamine; N-[3-Chloro-4-[(3-Fluorophenyl)Methoxy]Phenyl]-6-[5-[(2-Methylsulfonylethylamino)Methyl]-2-Furyl]Quinazolin-4-Amine; N-{3-Chloro-4-[(3-Fluorobenzyl) Oxy]Phenyl}-6-[5-({[2-(Methanesulphonyl) Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine; 4-{[3-Chloro-4-(3-Fluoro-Benzyloxy)-Phenyl]Amino}-6-(5-{[(2-Methanesulphonyl-Ethyl)Amino]Methyl}-Furan-2-Yl)Quinazoline; 4-Quinazolinamine, N-[3-Chloro-4-[(3-Fluorophenyl)Methoxy]Phenyl]-6-[5-[[[2-(Methylsulfonyl)Ethyl]Amino]Methyl]-2-Furanyl]-; Lapatinib(Tinibs); Lapatinib Base; N-[3-Chloro-4-[(3-Fluorophenyl)Methoxy]Phenyl]-6-[5-[[[2-(Methylsulfonyl)Ethyl]Amino]Methyl]-2-Furanyl]-4-Quinazolinamine; N-(3-Chloro-4-((3-Fluorobenzyl)Oxy)Phenyl)-6-(5-(((2-(Methylsulfonyl)Ethyl)Amino)Methyl)Furan-2-Yl)Quinazolin-4-Amine
Brief Introduction
Lapatinib is an oral reversible small molecule tyrosine kinase inhibitor targeting her-1/ HER-2. The biological effect of this mode of action on inhibiting the proliferation and growth of tumor cells is much greater than that of inhibiting only one of the targets. The so-called targeted therapeutic drugs refer to the drugs that target some receptors, genes or key proteins, and then targeted to kill the relevant tumor cells.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!